WELMYLI

Serial Number 98615017
Registration 7814801
700

Registration Progress

Application Filed
Jun 24, 2024
Under Examination
Approved for Publication
Apr 15, 2025
Published for Opposition
Apr 15, 2025
Registered
Jun 3, 2025

Trademark Image

WELMYLI

Basic Information

Serial Number
98615017
Registration Number
7814801
Filing Date
June 24, 2024
Registration Date
June 3, 2025
Published for Opposition
April 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 3, 2025
Registration
Registered
Classes
005 010

Rights Holder

Ascendis Pharma Growth Disorders A/S

99
Address
Tuborg Boulevard 12
Hellerup 2900
DK

Ownership History

Ascendis Pharma Growth Disorders A/S

Original Applicant
99
Hellerup DK

Ascendis Pharma Growth Disorders A/S

Owner at Publication
99
Hellerup DK

Ascendis Pharma Growth Disorders A/S

Original Registrant
99
Hellerup DK

Legal Representation

Attorney
Shannon Marie McKeon

USPTO Deadlines

Next Deadline
2136 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
Due Date
June 03, 2031
Grace Period Ends
December 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description Documents
Jun 3, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 3, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 21, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 21, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 21, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 21, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 21, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 11, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 29, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 29, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 29, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 24, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasia, achondroplasia and hypochondroplasia; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia
Class 010
Drug delivery devices sold empty, namely, medical devices for injection, syringes for injection, and infusion and injection devices for administering drugs that control the dosage of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; medical devices for dosage and injection of pharmaceutical and medical preparations, namely pen-type syringes, medical auto-injectors, autoinjector syringes, injection needles, and autoinjector cartridges; Syringes for medical purposes and for injections; Syringes for injection for medical use, namely syringes in the form of pens for medical and surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia, namely displays, monitors, controllers for medical fluid injectors, mobile apps used for data delivery and collection, ingestible sensors; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for medical diagnostic purposes, namely, dosage management dispensers being dosage dispensers for medicines containing pre-embedded or installed software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers being dosage dispensers for administering medicine to patients containing pre-installed or embedded software for medical information management, for guidance and control of medicines, and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Classification

International Classes
005 010